ZEISS Hosts Myopia Innovation Summit in Vancouver Introducing MyoActive Lens

ZEISS convened eye care professionals at the JW Marriott Parq Vancouver on October 4 for its Myopia Innovation Summit. The event introduced ZEISS MyoActive, a spectacle lens for children utilizing MOVE technology. Clinical data from an ongoing two-year randomized controlled trial (NCT06563700) in Shanghai indicated that MyoActive delivered an average efficacy of 0.60 D less spherical equivalent refractive error progression compared to single-vision lenses over twelve months, with 98% of children adapting within one week. Sessions featured presentations by Professor Padmaja Sankaridurg, Dr. Debbie Jones, Dr. Wes McCann, and Dr. Evelyn Lo, covering scientific evidence, measurement importance, glaucoma assessment, and practice management. Hands-on demonstrations linked diagnostics to patient communication. The summit series continues in Montréal on October 17 and Toronto on October 25.